Mount Sinai Hospital, Rebecca MacDonald Centre for Arthritis and Autoimmune Diseases, Toronto, ON M5T 3L9, Canada.
J Rheumatol. 2012 Aug;39(8):1555-8. doi: 10.3899/jrheum.110208. Epub 2011 Sep 1.
To describe Canadian clinical practice patterns in the pharmacological management of rheumatoid arthritis (RA) and identify practice variations.
A 44-item pre-guideline needs assessment survey was sent to all members of the Canadian Rheumatology Association (CRA). Descriptive statistics were used to summarize respondent characteristics and practice patterns.
Survey respondents (n = 164) reported variations in practice regarding assessment strategies, treatment with disease-modifying antirheumatic drug monotherapy versus combination therapy, methotrexate dosing and escalation, corticosteroid strategies, and optimal use of biologics.
Practice variations identified in this pre-guideline needs assessment survey were used to formulate key treatment questions for the development of CRA recommendations.
描述加拿大在类风湿关节炎(RA)药物治疗管理方面的临床实践模式,并确定实践差异。
向加拿大风湿病学会(CRA)的所有成员发送了一份包含 44 个项目的指南前需求评估调查。使用描述性统计来总结受访者的特征和实践模式。
调查受访者(n=164)报告了在评估策略、疾病修饰抗风湿药物单药治疗与联合治疗、甲氨蝶呤剂量和升级、皮质类固醇策略以及生物制剂的最佳使用方面存在实践差异。
本指南前需求评估调查中确定的实践差异被用于制定 CRA 建议制定的关键治疗问题。